Miscellaneous Causes of Bronchiolitis: Inhalational, Infectious, Drug-Induced, and Idiopathic

Seminars in Respiratory and Critical Care Medicine

Volumn 24, Issue 5, 2003, Pages 567-576

  King Jr , Talmadge E ^a,b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bronchiolitis; Bronchiolitis obliterans; Diffuse panbronchiolitis; Inhalational injury; Volatile flavoring agents

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHEMICAL AGENT; CLARITHROMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ERYTHROMYCIN; FLAVORING AGENT; IPRATROPIUM BROMIDE; MACROLIDE; PENICILLAMINE; PREDNISOLONE; ROXITHROMYCIN;

AIRWAY OBSTRUCTION; BRONCHIOLITIS; CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; INFECTION; INFLAMMATION; INHALATION; NOMENCLATURE; ORGANIC DUST; PRIORITY JOURNAL; RADIOGRAPHY; REVIEW;

EID: 0346750928     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815604     Document Type: Review

References (122)

1. King TE Jr. Bronchiolitis. In: Schwarz MI, King TE, Jr, eds. Interstitial Lung Diseases. 4th ed. Hamilton, Ontario, Canada: BC Decker; 2003
2. Becklake MR, Goldman HI, Bosman AR, Freed CC. The long-term effects of exposure to nitrous fumes. Am Rev Tuberc 1957;76:398-409
3. Ramirez RJ, Dowell AR. Silo-filler's disease: nitrogen dioxide-induced lung injury: long-term follow-up and review of the literature. Ann Intern Med 1971;74:569-576
4. Jones GR, Proudfoot AT, Hall JI. Pulmonary effects of acute exposure to nitrous fumes. Thorax 1973;28:61-65
5. Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anesthesia. Br J Anaesth 1967;39:388-392
6. Fleming GM, Chester EH, Montenegro HD, Dysfunction of small airways following pulmonary injury due to nitrogen dioxide. Chest 1979;75:720-721
7. Sobonya R. Fatal anhydrous ammonia inhalation. Hum Pathol 1977;8:293-299
8. Burns TR, Mace ML, Greenberg SD, Jachimczyk JA. Ultrastructure of acute ammonia toxicity in the human lung. Am J Forensic Med Pathol 1985;6:204-210
9. Koren HS, Devlin RB, Graham DE, et al. Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989;139:407-415
10. Graham DE, Koren HS. Biomarkers of inflammation of ozone-exposed humans: comparison of the nasal and bronchoalveolar lavage. Am Rev Respir Dis 1990;142:152-156
11. Paulo M, Gong HJ, Respiratory effects of ozone: whom to protect, when, and how? J Respir Dis 1991;12:482-499
12. Tyler WS, Julian MD, Hyde DM. Respiratory bronchiolitis following exposures to photochemical air pollutants. Sem Respir Med 1992;13:94-113
13. Wright JL. Inhalational lung injury causing bronchiolitis. Clin Chest Med 1993;14:635-644
14. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome: persistent asthma syndrome after high irritant exposures. Chest 1985;88:376-384
15. Troisi FM. Delayed death caused by gassing in a silo containing green forage. Br J Ind Med 1957;14:56-58
16. Horvath EP, Colico DGA, Barbee RA, Dickie HA. Nitrogen dioxide-induced pulmonary disease. J Occ Med 1978;20:103-110
17. Milne JEH. Nitrogen dioxide inhalation and bronchiolitis obliterans. J Occup Med 1969;11:538-547
18. Yockey CC, Eden BM, Byrd RB. The McConnel missile accident: clinical spectrum of nitrogen dioxide exposure. JAMA 1980;244:1221-1223
19. Moskowitz RL, Lyons HA, Cottle HR. Silo-filler's disease: clinical, physiologic and pathologic study of patient. Am J Med 1964;36:457-462
20. Prowse K. Nitrous fume poisoning. Bull Europ Physiopath Resp 1977;13:191-202
21. Scott EU, Hunt WB. Silo-filler's disease. Chest 1973;63:701-706
22. Rafii S, Godwin MD. Relapse following latent period. Arch Path 1961;72:424-433
23. Douglas WW, Norman G, Hepper G, Colby TV. Silo-filler's disease. Mayo Clin Proc 1989;64:291-304
24. Woodford DM, Coutu RE, Gaensler EA. Obstructive lung disease from acute sulfur dioxide exposure. Respiration (Herrlisheim) 1979;38:238-245
25. Eichenberger A, Weber J, Hausser E. Pneumopathic des ensileus (silo-filler's disease). Schweiz Med Wschr 1966;96:1652-1655
26. Tse RL, Bockman AA. Nitrogen dioxide toxicity: report of four cases in firemen. JAMA 1970;212:1341-1344
27. Rigner KG, Swensson A, Late prognosis of nitrous fume poisoning and follow-up study. Acta Med Scand 1961;170:291-299
28. Kern DG, Crausman RS, Durand KT, Nayer A, Kuhn C III. Flock worker's lung: chronic interstitial lung disease in the nylon flocking industry. Ann Intern Med 1998;129:261-272
29. Kern DG, Kuhn C III, Ely EW, et al. Flock worker's lung: broadening the spectrum of clinicopathology, narrowing the spectrum of suspected etiologies. Chest 2000;117:251-259
30. Boag AH, Colby TV, Fraire AE, et al. The pathology of interstitial lung disease in nylon flock workers. Am J Surg Pathol 1999;23:1539-1545
31. Weiland DA, Lynch DA, Jensen SP, et al. Thin-section CT findings in flock worker's lung: a work-related interstitial lung disease. Radiology 2003;227:222-231
32. From the Centers for Disease Control and Prevention. Fixed obstructive lung disease in workers at a microwave popcorn factory-Missouri, 2000-2002. JAMA 2002;287:2939-2940
33. Fixed obstructive lung disease in workers at a microwave popcorn factor-Missouri, 2000-2002. MMWR Morb Mortal Wkly Rep 2002;51:345-347
34. Lockey J, McKay R, Barth E, Dahlsten J, Baughman R. Bronchiolitis obliterans in the food flavoring manufacturing industry. Am J Respir Crit Care Med 2002;165:A461
35. Kreiss K, Gomaa A, Kullman G, et al. Endemic bronchiolitis obliterans syndrome in microwave popcorn workers: a new occupational lung hazard. Am J Respir Crit Care Med 2002;165:A461
36. Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes EJ, Enright PL. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med 2002;347:330-338
37. Akpinar-Elci M, Kanwal R, Kreiss K. Bronchiolitis obliterans syndrome in popcorn plant workers. Am J Respir Crit Care Med 2002;165:A526
38. Lynch DA. Imaging of small airway disease. In: Kreiss K, ed. Bronchiolitis Obliterans in New Occupational Settings: Developing a Clinical and Public Health Approach, August 25, 2001. Morgantown, WV: National Institute for Occupational Safety and Health (NIOSH); 2001
39. Parmet AJ, Von Essen S. Rapidly progressive, fixed airway obstructive disease in popcorn workers: a new occupational pulmonary illness? J Occup Environ Med 2002;44:216-218
40. Schachter EN. Popcorn worker's lung. N Engl J Med 2002;347:360-361
41. Wohl MEB, Chernick V. Bronchiolitis: state of the art. Am Rev Respir Dis 1978;118:759-781
42. Smith CB, Overall CJJ. Clinical and epidemiologic clues to the diagnosis of respiratory infections. Radiol Clin North Am 1973;11:261-278
43. Penn CC, Liu C. Bronchiolitis following infection in adults and children. Clin Chest Med 1993;14:645-654
44. Wohl MEB. Bronchiolitis in children. In: Epler GR, ed. Diseases of the Bronchioles. New York: Raven; 1994:397-407
45. Hardy KA. Childhood bronchiolitis obliterans. In: Epler GR, ed. Diseases of the Bronchioles. New York: Raven Press; 1994:415-426
46. Coultas DB, Funk LM. Postinfectious bronchiolitis obliterans. In: Epler GR, ed. Diseases of the Bronchioles. New York: Raven; 1994:215-229
47. Ham JC. Acute infectious obstructing bronchiolitis: a potentially fatal disease in the adult. Ann Intern Med 1964;60:47-60
48. Harris C. Acute obstructive bronchiolitis: presentation of fatal case. JAMA 1965;194:203-205
49. Dines DE. Acute bronchiolitis as a cause of chronic obstructive lung disease in adults: report of two cases. Lancet 1967;87:281-282
50. Marinopoulos GC, Huddle KR, Wainwright H. Obliterative bronchiolitis: virus induced? Chest 1991;99:243-245
51. Gosink BB, Friedman PJ, Liebow AA. Bronchiolitis obliterans: roentgenologic-pathologic correlation. Am J Roentgenol Radium Ther Nucl Med 1973;117:816-832
52. Breatnach E, Kerr I. The radiology of cryptogenic obliterative bronchiolitis. Clin Radiol 1982;33:657-661
53. Green M. Bronchiolitis. In: Sadaul P, Milic-Emili J, Simonsson BG, Clark TJH, eds. Small Airways in Health and Disease. Amsterdam: Excerpta Medica (ICS 485); 1979:90-94
54. Wohl ME. Present capacity to evaluate pulmonary function relevant to bronchiolitis. Pediatr Res 1977;11(3 pt 2):252-253
55. McLean KH. The pathology of acute bronchiolitis: a study of its evolution, II: The repair phase. Aust Ann Med 1957;6:29-43
56. McLean KH. The pathology of acute bronchiolitis: a study of its evolution, I: The exudative phase. Aust Ann Med 1956;5:254-267
57. Mauad T, Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol 2002;33:466-474
58. Friis B, Andersen P, Brene E, et al. Antibiotic treatment of pneumonia and bronchiolitis: a prospective randomised study. Arch Dis Child 1984;59:1038-1045
59. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, Mcdowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991;118:807-811
60. Caramia G, Palazzini E. Efficacy of ribavirin aerosol treatment for respiratory syncytial virus bronchiolitis in infants. J Int Med Res 1987;15:227-233
61. Hefelfinger DC. Bronchiolitis: a clearer picture is emerging. J Respir Dis 1986;7(11):17-27
62. Mellins RB. Bronchiolitis: comments on pathogenesis and treatment. Pediatr Res 1977;11:268-269
63. Ellis EF. Therapy of acute bronchiolitis. Pediatr Res 1977;11:263-264
64. Hall VVJ, Hall CB. Clinical significance of pulmonary function tests: alterations in pulmonary function following respiratory vital infection. Chest 1979;76:458-465
65. McConnochie KM, Roghmann KJ. Predicting clinically significant lower respiratory tract illness in childhood following mild bronchiolitis. Am J Dis Child 1985;139:625-631
66. McIntosh K. Bronchiolitis and asthma: possible common pathogenetic pathways. J Allergy Clin Immunol 1976;57:595-604
67. Twiggs JT, Larson LA, O'Connell EJ, Ilstrup DM. Respiratory syncytial virus infection: ten-year follow-up. Clin Pediatr (Phila) 1981;20:187-190
68. Weiss ST, Tager IB, Munoz A, Speizer FE. The relationship of respiratory infections in early childhood to the occurrence of increased levels of bronchial responsiveness and atopy. Am Rev Respir Dis 1985;131:573-579
69. McConnochie KM, Mark JD, McBride JT, et al. Normal pulmonary function measurements and airway reactivity in childhood after mild bronchiolitis. J Pediatr 1985;107:54-58
70. Holness I, Tenebaum J, Cooter NB, Grossman RF. Fatal bronchiolitis obliterans associated with chrysotherapy. Ann Rheum Dis 1983;42:593-596
71. Turner-Warwick M. Adverse reactions affecting the lung: possible association with D-penicillamine. J Rheumatol 1981;7:166-168
72. Camus P. The respiratory complications of D-penicillamine therapy (author's translation). Rev Fr Mal Respir 1982;10:7-20
73. Yam LY, Wong R. Bronchiolitis obliterans and rheumatoid arthritis: report of a case in a Chinese patient on D-penicillamine and review of the literature. Ann Acad Med Singapore 1993;22:365-368
74. Lin TJ, Lu Lu CC, Chen KW, Deng JF. Outbreak of obstructive ventilatory impairment associated with consumption of Sauropus androgynus vegetable. J Toxicol Clin Toxicol 1996;34:1-8
75. Lai RS, Chiang AA, Wu Wu MT, et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 1996;348:83-85
76. Chen CW, Hsiue TR, Chen KW, Chang HY, Chen CR, Yang BC. Increased IL-5 and IL-10 transcription in bronchial cells after Saurpus androgynus ingestion. J Formos Med Assoc 1996;95:699-702
77. Chang H, Wang JS, Tseng HH, Lai RS, Su JM. Histopathological study of Sauropus androgynus-associated constrictive bronchiolitis obliterans: a new cause of constrictive bronchiolitis obliterans. Am J Surg Pathol 1997;21:35-42
78. Yang CF, Wu MT, Chiang AA, et al. Correlation of high-resolution CT and pulmonary function in bronchiolitis obliterans: a study based on 24 patients associated with consumption of Sauropus androgynus. Am J Roentgenol 1997;168:1045-1050
79. Wang JS, Tseng HH, Lai RS, Hsu HK, Ger LP. Sauropus androgynus-constrictive obliterative bronchitis/bronchiolitis-histopathological study of pneumonectomy and biopsy specimens with emphasis on the inflammatory process and disease progression. Histopathology 2000;37:402-410
80. Chang YL, Yao YT, Wang NS, Lee YC. Segmental necrosis of small bronchi after prolonged intakes of Sauropus androgynus in Taiwan. Am J Respir Crit Care Med 1998;157:594-598
81. Turton CW, William G, Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax 1981;36:805-810
82. Dorinsky PM, Davis WB, Lucas JG, Weiland JE, Gadek JE. Adult bronchiolitis: evaluation by bronchoalveolar lavage and response to prednisone therapy. Chest 1985;88:58-63
83. Kindt GC, Weiland JE, Davis VVB, Gadek JE, Dorinsky PM. Bronchiolitis in adults: a reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis 1989;140:483-492
84. Meier-Sydow J, Schneider M, Rust M. Chronic bronchiolitis in adults. Eur J Respir Dis 1986;69(suppl. 146):337-344
85. Kraft M, Mortenson RL, Colby TV, Newman L, Waldron J Jr, King TE Jr. Cryptogenic constrictive bronchiolitis. Am Rev Respir Dis 1993;148:1093-1101
86. Edwards C, Cayton R, Bryan R. Chronic transmural bronchiolitis: nonspecific lesion of small airways. J Clin Pathol 1992;45:993-998
87. Jensen SP, Lynch DA, Brown KK, Wenzel SE, Newell JD. High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin Radiol 2002;57:1078-1085
88. Homma H, Yamanaka A, Tanimoto S, et al. Diffuse panbronchiolitis: a disease of the transsitional zone of the lung. Chest 1983;83:63-69
89. Izumi T. A nation-wide survey of diffuse panbronchiolitis in Japan. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and Other Granulomatous Disorders. New York: Elsevier Science; 1988:753-757
90. Sugiyama Y. Diffuse panbronchiolitis. Clin Chest Med 1993;14:765-772
91. Fisher MS Jr, Rush WL, Rosado-de-Christenson ML, et al. Diffuse panbronchiolitis: histologic diagnosis in unsuspected cases involving North American residents of Asian descent. Arch Pathol Lab Med 1998;122:156-160
92. Randhawa P, Hoagland MH, Yousem SA. Diffuse panbronchiolitis in North America: report of three cases and review of the literature. Am J Surg Pathol 1991;15:43-47
93. Poletti V, Patelli M, Poletti G, Bertanti T, Spiga L. Diffuse panbronchiolitis observed in an Italian (letter). Chest 1990;98:515-516
94. Homer RJ, Khoo L, Smith GJ. Diffuse panbronchiolitis in a Hispanic man with travel to Japan. Chest 1995;107:1176-1178
95. Fitzgerald JE, King TE Jr, Lynch DA, Tuder RM, Schwarz MI. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med 1996;154:497-503
96. Martinez JA, Guimaraes SM, Ferreira RG, Pereira CA. Diffuse panbronchiolitis in Latin America. Am J Med Sci 2000;319:183-185
97. Souza R, Kairalla RA, Santos Ud Ude P, Takagaki TY, Capelozzi VL, Carvalho CR. Diffuse panbronchiolitis: an underdiagnosed disease? Study of 4 cases in Brazil. Rev Hosp Clin Fac Med Sao Paulo 2002;57(4):167-174
98. Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1990;141:1459-1462
99. Yamanishi Y, Maeda H, Hiyama K, Ishioka S, Yamakido M. Rheumatoid arthritis associated with diffuse panbronchiolitis. Intern Med 1998;37:338-341
100. Ono K, Shimamoto Y, Matsuzaki M, et al. Diffuse panbronchiolitis as a pulmonary complication in patients with adult T-cell leukemia. Am J Hematol 1989;30:86-90
101. Koga T. Neutrophilia and high level of interleukin 8 in the bronchoalveolar lavage fluid of diffuse panbronchiolitis. Kurume Med J 1993;40:139-146
102. Kawakami K, Kadota J, Iida K, et al. Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells. Clin Exp Immunol 1997;107:410-416
103. Nakano H, Ide H, Imada M, et al. Reduced nasal nitric oxide in diffuse panbronchiolitis. Am J Respir Crit Care Med 2000;162:2218-2220
104. Sueyasu Y. Diffuse panbronchiolitis: a thin-section CT scoring system. Kurume Med J 1996;43:63-71
105. Iwata M, Colby TV, Kitaichi M. Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations. Hum Pathol 1994;25:357-363
106. Baz MA, Kussin PS, Trigt PV, Davis RD, Roggli VL, Tapson VF. Recurrence of diffuse panbronchiolitis after lung transplantation. Am J Respir Crit Care Med 1995;151:895-898
107. Goldstein BG, Goldstein AO. Pemphigus and bullous pemphigoid. In: Rose BD, ed. UpToDate. Wellesley, MA: UpToDate; 2002
108. Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323:1729-1735
109. Kimyai-Asadi A, Jih MH. Paraneoplastic pemphigus. Int J Dermatol 2001;40:367-372
110. Nousari HC, Deterding R, Wojtczack H, et al. The mechanism of respiratory involvement in paraneoplastic pemphigus. N Engl J Med 1999;340:1406-1410
111. Fullerton SH, Woodley DT, Smoller BR, Anhalt GJ. Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA 1992;267:1500-1502
112. Saito K, Morita M, Enomoto K. Bronchiolitis obliterans with pemphigus vulgaris and Castleman's disease of hyaline-vascular type: an autopsy case analyzed by computer-aided 3-D reconstruction of the airway lesions. Hum Pathol 1997;28:1310-1312
113. Kim SC, Chang SN, Lee IJ, et al. Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 1998;138:667-671
114. Chorzelski T, Hashimoto T, Maciejewska B, Amagai M, Anhalt G, Jablonska S. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol 1999;41:393-400
115. Hasegawa Y, Shimokata K, Ichiyama S, Saito H. Constrictive bronchiolitis obliterans and paraneoplastic pemphigus. Eur Respir J 1999;13:934-937
116. Wolff H, Kunte C, Messer G, et al. Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Br J Dermatol 1999;140:313-316
117. Takahashi M, Shimatsu Y, Kazama T, Kimura K, Otsuka T, Hashimoto T. Paraneoplastic pemphigus associated with bronchiolitis obliterans. Chest 2000;117:603-607
118. van der Waal RI, Pas HH, Nousari HC, et al. Paraneoplastic pemphigus caused by an epithelioid leiomyosarcoma and associated with fatal respiratory failure. Oral Oncol 2000;36:390-393
119. Chin AC, Stich D, White FV, Radhakrishnan J, Holterman MJ. Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: a rare case of Castleman's disease with respiratory failure requiring lung transplantation. J Pediatr Surg 2001;36:E22
120. Cordel N, Ringeisen F, Antoine M, Cadranel J, Aractingi S. Paraneoplastic pemphigus with constrictive bronchiolitis obliterans. Dermatology 2001;202:145
121. Fujimoto W, Kanehiro A, Kuwamoto-Hara K, et al. Paraneoplastic pemphigus associated with Castleman's disease and asymptomatic bronchiolitis obliterans. Eur J Dermatol 2002;12:355-359
122. Osmanski JP II, Fraire AE, Schaefer OP. Necrotizing tracheobronchitis with progressive airflow obstruction associated with paraneoplastic pemphigus. Chest 1997;112:1704-1707